Back

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing pulmonary vein isolation and ablation for atrial fibrillation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Catheter ablation of atrial fibrillation: efficacy and complications Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mouna Kodali

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)

7 More presentations in this session

Presentation thumbnail
Left atrial posterior wall isolation using pulsed-field ablation: procedural characteristics, safety, myocardial injury and short-term outcomes
Mr S. Weidlich (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Predicting success of atrial fibrillation ablation: comparing machine learning approaches of intracardiac electrograms
Mr S. Ruiperez-Campillo (Zurich, CH)
Abstract Slides
Presentation thumbnail
Anemia and atrial fibrillation ablation recurrence: insights from a large-scale multicentre registry
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
A novel designed atrial septum linear ablation method (Icho line) for non-pulmonary vein triggers originating from atrial postero-septum and crista terminalis
Doctor S. Kawai (Iizuka, JP)
Abstract Slides Video
Presentation thumbnail
Sex-based differences and outcomes in patients undergoing pulmonary vein isolation for atrial fibrillation
Ms A. Aguiar Neves (Vila Nova de Gaia, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation of atrial fibrillation: efficacy and complications

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources